β 1, 3-Glucan in Cancer Treatment
Vaclav Vetvicka1 & J. Vetvickova1 Show affiliations
- University of Louisville, United States
American Journal of Immunology, Volume 8, Issue 2, pp. 38–43 · doi.org/10.3844/ajisp.2012.38.43
Abstract
Natural products, useful in preventing and/or treating various diseases, have been sought after throughout the man’s history. Despite some problems inherited from the natural source of glucans, there is extensive literature about their activities in animal tumor models. For the past 25 years, Japan has used several forms of mushroom-derived glucans in treating cancer patients. Additionally, close to twenty clinical trials are currently running in several countries, further suggesting the strong possibility of using glucans as an established anti-cancer drug.
Licence and reuse
Free to read. This article carries the publisher’s copyright, as printed on it: © 2012 Science Publications. It is free to read; ask us before reusing it.
How to reuse this articleResponses (0)
About this article
Vetvicka, V. & Vetvickova, J. (2012). β 1, 3-Glucan in Cancer Treatment. American Journal of Immunology, 8(2), 38–43. https://doi.org/10.3844/ajisp.2012.38.43
- Licence
- © Science Publications
- Issue
- Volume 8, Issue 2
- Policies
- Editorial independenceUse of generative AIData availabilityAppeals and complaints
- Version
- Version of record
